Abstracts should be submitted through the website (www.CWIG2017.com) using the online submission system only. Abstracts submitted by fax will not be accepted. All abstracts must be submitted in English by the new deadline of March 31st 2017 (at midnight Italian CET UTC+2)

You can submit abstract for:



Pectus excavatum

  • Indications
  • Age at operation
  • Preoperative treatment
  • Conservative Treatment
  • The role of prosthetic treatment
  • Nuss technique and modifications

Pectus carinatum

  • Indications
  • Age at operation
  • Compression systems
  • Open Treatment
  • Reverse Nuss (Abramson’s technique)

Pectus Arcuatum

Bio-engineering solutions in chest wall disorders

Chest wall trauma

Chest wall infections

Chest wall tumors

Genetic of chest wall disorders

New diagnostic-therapeutic technologies in chest wall pathologies

Pain management in surgically treated patients

Poland’s Syndrome and allied disorders

Psychological Evaluation of patients with chest wall deformities

TOS - Thoracic Outlet Syndrome


At least one author per submitted paper must be registered for the conference. Abstracts for which no author has registered for the conference, will not be included in the abstract book. Please note that abstract submission username and password are different from congress registration passwords.

The presenting author is required to ensure that all co-authors are aware of the content of the abstract before submission. Abstracts must be original and must not have been presented previously or submitted to any other meeting.

Please insert your abstract text in the fields: we suggest you to "Copy and Paste" the abstract text from a saved document file, please avoid to type the text directly in the boxes, you have only 20 minutes at your disposal.
Please note that you can change only abstract text: no other changes can be done.

All abstracts must be submitted by the new deadline of March 31st 2017 at midnight Italian CET UTC+2) and authors must register for the conference; please note that early bird registration fee new deadline is March 31st 2017.

Notification of abstract acceptance will be sent to you by email by April 30th, 2017.

Rules for Submission

  • All abstracts must be submitted and presented in clear English with accurate grammar and spelling, in a quality suitable for publication. If you need help, please arrange for the review of your abstract by a colleague who is a native English speaker, by a university scientific publications office (or other similar facility) or by a copy editor, prior to submission.
  • The author is expected to attend the congress and present the poster.

Before you begin, please prepare the following information:

Author and co-authors’ details –

  • Full first and family name(s)
  • Affiliation details: department, institution / hospital, city, state (if relevant), country
  • Presenting author’s contact details
  • Email address
  • Full postal address
  • Daytime phone number

Abstract structure

Abstract title: limited to 20 words
Abstract text: limited to 300 words (more will be delayed). Please note: word count is affected when graphs/tables/images are added.

Abstract layout

Abstracts must be submitted with the following sections:

  • Background and aims
  • Methods
  • Results
  • Conclusions

Tables: a maximum of one table of up to 10 rows x 10 columns can be included per abstract.
Graphs and images: it is important to note that an image included in the abstract is worth 50 words. A maximum of one image can be included per abstract.
The maximum file size of each graph/image is 500 KB. The maximum pixel size of the graph/image is 600(w) x 800(h) pixel. You may upload graphs in JPG format only.
Draft abstracts: the submission form at the link below allows you to store your abstract as a draft in order to make changes.

Please note that abstracts must be submitted before the deadline in order to be sent to review for inclusion in the scientific program.

Conditions of acceptance

The content and literary standard of submitted abstracts are the author's responsibility and cannot be corrected after submission. All abstracts will initially be reviewed, graded and accepted or rejected by the Scientific Committee: they also reserve the right to determine whether a submission is accepted as an oral or poster presentation, or if it has to be set in an alternative thematic session than the one suggested by the authors.

Final instructions for poster or oral presentations will be included in the notification of acceptance.

Please be advised that you will be requested to confirm the following information when you submit your abstract.

  1. I confirm that I previewed this abstract and that all information is correct. I accept that the content of this abstract cannot be modified or corrected after final submission and I am aware that it will be published exactly as submitted.
  2. Submission of the abstract constitutes my consent to publication (e.g. congress website, programmes, other promotions, etc.).
  3. The abstract submitter warrants and represents that he/she is the sole owner or has the rights of all the information and content (“Content”) provided to CWIG 2017 Congress. The publication of the abstract does not infringe any third party rights including, but not limited to, intellectual property rights. The abstract submitter grants the Organizers a royalty-free, perpetual, irrevocable nonexclusive license to use, reproduce, publish, translate, distribute, and display the content.
  4. The Organizers reserve the right to remove from any publication an abstract, which does not comply with the above.
  5. I herewith confirm that the contact details saved in this system are those of the corresponding author, who will be notified about the status of the abstract. The corresponding author is responsible for informing the other authors about the status of the abstract.


Only work that has received local animal or human ethics committee approval as appropriate will be considered for presentation and publication. A statement indicating ethics committee approval should be incorporated into the abstract and you will be requested to confirm that approval has been applied for/granted before you submit your abstract. Abstracts which have not received approval will not be accepted – unless they fit into the special categories below:

Ethical committee approval is required for the following scenarios:

  1. Clinical trials
  2. Perspective data collection – unless local committee authorizes otherwise
  3. Anonymous retrospective data collection – unless local committee or laws authorize otherwise
  4. Audit study – unless local committee authorizes otherwise.

Ethical committee approval is NOT required for the following scenarios:

  1. Questionnaire survey of medical personnel
  2. Case studies – with patient consent
  3. Historical research
  4. Research performed on artificial model
  5. Evaluation performed during pre-operative session – with receipt of informed consent.

Notification of abstract acceptance

Notification of abstract acceptance will be sent to the presenting authors by email by April 30th, 2017.

Confirmation of receipt of abstracts

Presenting authors will be sent an automatic acknowledgement via e-mail to confirm that your abstract has been received.

Best Poster Competition

All accepted posters Presenting author under 40) will be automatically considered for the BEST POSTER AWARD


  • March 31st, 2017: abstract submission new deadline
  • March 31st 2017: early bird registration new deadline
  • April 30th, 2017: notification of abstract acceptance